MedTrace Logo

Cardiovascular Status in Patients With Endogenous Cortisol Excess (Cushing's Syndrome)

NCT03880513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2023-04-28

No results posted yet for this study

Summary

Within this trial, the cardiovascular and mental status as well as the metabolic profiles of patients with endogenous cortisol excess are evaluated.

Conditions

  • Endogenous Cushing's Syndrome

Interventions

DIAGNOSTIC_TEST

Cardiovascular status and quality of life

Psychosocial and cardiovascular evaluation includes medical history, physical examination, laboratory tests, analysis of endothelial function, 24h blood pressure profile, Holter ECG, transthoracic echocardiography, cardiac MRI, and quality of life assessment

Sponsors & Collaborators

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Martin Fassnacht, Professor · University Hospital Wuerzburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03880513 on ClinicalTrials.gov